Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-05-18 @ 1:43 PM
Study NCT ID:
NCT06587451
Status:
SUSPENDED
Last Update Posted:
2025-08-07
First Post:
2024-08-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy®
Sponsor:
Sandoz
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CJPB898A12301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None